The International Workshop on HIV Transmission includes the world's most prominent and distinguished speakers in the field.
Thursday, 12 December 2019 | ||
9:00 AM | Welcome | |
Session 1: Network Identification for Prevention - I Chairs: Walid Heneine & Charles Boucher | ||
9:10 AM | Bioinformatics Methods for Cluster Analysis Ellsworth Campbell CDC, USA | |
9:35 AM | Cluster Response and Implementation Colin Flynn Maryland Department of Health, USA | |
10:00 AM | Abstract: Natural Selection Favoring More Transmissible HIV Detected in U.S. Molecular Transmission Network. Author: Walid Heneine | |
10:15 AM | Abstract: Clusters of Diverse HIV and Novel Recombinants Identified Among Persons Who Inject Drugs in Kentucky and Ohio. Author: Anupama Shankar | |
10:30 AM | Discussion | |
11:15 AM | Coffee Break | |
Session 2: Network Identification for Prevention - II Chairs: Walid Heneine & Amy Killelea | ||
11:45 AM | Using Spatial Network Analysis of Mobile Phone Data to Design HIV Control Strategies Sally Blower UCLA, USA | |
12:10 PM | Abstract: Human Mobility Patterns Generate Geographically Structured Sub-epidemics in Namibia. Author: Eugenio Valdano | |
12:25 PM | Panel Discussion: | |
Ethical, legal and Scientific Perspectives Moderator: Amy Killelea, NASTAD, USA | ||
1:00 PM | LUNCH | |
Session 3: Early Events in Transmission - Animal Models Chairs: Eric Hunter & James Arthos | ||
2:00 PM | Preferential Transmission of Transmitted Founder Variants Over Non-Transmitted Donor Partner Variants in the Humanized Mouse Intravaginal Challenge Model Abstract: Daniel Claiborne | |
2:25 PM | Enhanced Protection at the Site of Challenge of Rhesus Macaques That Receive PGT121 One Week Prior to Intravaginal Challenge With SHIV-SF162P3 Jeff Schneider Rush Medical College, USA | |
2:45 PM | Abstract: The Capture of HIV-1 by Human PBMCs in the Presence of Broadly Neutralizing Antibodies Reveals Different Virus Capture Inhibition Profiles Between Infectious Molecular Clones and Primary Viruses. Author: Jiae Kim | |
3:00 PM | Abstract: Robust CAB-LA Protection of Macaques from Shiv Infection Despite Concomitant Double or Triple Sti Infection and Administration of Depot Medroxyprogesterone Acetate. Author: Ajay Vishwanathan | |
3:15 PM | Discussion: Which cells are involved in early transmission | |
3:45 PM | COFFEE BREAK | |
Session 4: Early events in Transmission - Human models / acute infection cohorts Chairs: Gabriella Scarlatti & Thumbi Ndung'u | ||
4:15 PM | Data on African Acute Cohort Studies (FRESH) | |
4:35 PM | Current and Future Work on the MHRP Acute Infection Cohorts Merlin Robb Henry M. Jackson Foundation, USA | |
4:55 PM | Abstract: Ex Vivo Rectal Explant Challenge Model of HIV-1 Transmission Reveals Associations Between Endogenous Inflammatory Cytokine Production and HIV Replication. Author: Phillip Murray | |
5:10 PM | Abstract: Preliminary Transcriptome Analysis Reveals Immune Signatures Associated with Support of HIV Replication in Ex Vivo Challenged Rectal Mucosa. Author: Abigail Smith | |
5:25 PM | Abstract: The Distribution of Rectal Mucosal CD4 and CD8 Tissue Resident and Non-Tissue Resident Subsets and their Associations with HIV-1 Infectivity in the ex vivo Rectal Explant Challenge Model. Author: Grimsley Ackerley | |
5:40 PM | Discussion | |
6:15 PM | End of Day 1 | |
Welcome Reception | ||
Friday, 13 December 2019 | ||
Session 5: Risk Factors of HIV Transmission in Adolescents Chairs: Thumbi Ndung'u & Phyllis Kanki | ||
9:00 AM | Social and Behavioral Aspects of HIV Transmission in Adolescents Susannah Allison National Institute of Mental Health, USA | |
9:20 AM 9:40 AM | Biological Differences; Vaginal Transmission/ Mucosal Injury Biological Differences; Rectal Transmission/ Mucosal Injury | |
10:00 AM | Abstract: Pharmacology of Potential Event-driven Dosing Regimens for HIV Prevention Among Men Who Have Sex with Men. Author: Richard Haaland | |
10:15 AM | Abstract: On-demand Pre- and Post-exposure Prophylaxis by Vaginal Inserts Containing TAF and EVG in Macaques. Author: Charles Dobard | |
10:30 AM | Discussion | |
11:00 AM | COFFEE BREAK | |
Session 6: Novel Antiviral Agents and Delivery Systems Chairs: Charles Boucher & Thomas Hope | ||
11:30 AM | Pre-clinical Animal Work on Ab's (imaging) Thomas Hope Northwestern University, USA | |
11:55 AM | Passive and Vectored Immunoprophylaxis for HIV Prevention David Garber CDC, USA | |
12:20 PM | BnAbs for Clinical Use: How far are we? Julie Ledgerwood NIH, USA | |
12:45 PM | Discussion | |
1:00 PM | End of the program | |